Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Amniocentesis; diagnostic

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

Amniocentesis is a medical procedure utilized for diagnostic purposes during pregnancy. It involves the careful insertion of a needle through the abdominal wall and into the uterus, reaching the amniotic sac that surrounds the developing fetus. This procedure is typically guided by ultrasound to ensure precision and safety. The primary goal of amniocentesis is to aspirate, or withdraw, a sample of amniotic fluid, which contains fetal cells and various substances that can provide valuable information about the fetus's health and development. This procedure is generally performed between the 12th and 18th weeks of gestation, a critical period for obtaining accurate diagnostic information. After the fluid is collected, the needle is withdrawn, completing the procedure. Amniocentesis can help in diagnosing genetic disorders, chromosomal abnormalities, and certain infections, making it an important tool in prenatal care.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

Amniocentesis is performed for several specific indications during pregnancy, particularly when there is a need for detailed fetal assessment. The following conditions may warrant the use of this diagnostic procedure:

  • Genetic Disorders Amniocentesis is indicated for the detection of genetic disorders such as Down syndrome, cystic fibrosis, and other chromosomal abnormalities.
  • Fetal Development Issues The procedure may be performed to assess fetal development and identify potential issues that could affect the health of the fetus.
  • Maternal Age Women of advanced maternal age (typically 35 years or older) may be recommended to undergo amniocentesis due to an increased risk of chromosomal abnormalities.
  • Family History A family history of genetic disorders may also indicate the need for amniocentesis to evaluate the risk of these conditions in the fetus.
  • Abnormal Screening Results If preliminary screening tests indicate a potential risk for genetic conditions, amniocentesis may be performed for confirmation.

2. Procedure

The procedure of amniocentesis involves several critical steps to ensure safety and accuracy. The following outlines the procedural steps involved:

  • Step 1: Preparation The patient is positioned comfortably, typically lying on her back, and the abdomen is cleaned with an antiseptic solution to minimize the risk of infection. An ultrasound is performed to locate the position of the fetus and the amniotic sac, ensuring that the needle can be inserted safely.
  • Step 2: Needle Insertion Under continuous ultrasound guidance, a thin, sterile needle is carefully inserted through the abdominal wall and into the uterus. The physician takes great care to avoid any blood vessels and to ensure that the needle is directed towards the amniotic sac.
  • Step 3: Aspiration of Amniotic Fluid Once the needle is correctly positioned within the amniotic sac, a small amount of amniotic fluid is aspirated using a syringe attached to the needle. This fluid contains fetal cells and other substances that are crucial for diagnostic testing.
  • Step 4: Needle Withdrawal After the required amount of fluid has been collected, the needle is carefully withdrawn from the uterus and abdomen. The site of insertion is then cleaned and may be covered with a sterile bandage.

3. Post-Procedure

Following the amniocentesis procedure, patients are typically monitored for a short period to ensure there are no immediate complications. It is common to experience mild cramping or discomfort at the insertion site, which usually resolves quickly. Patients are advised to rest for the remainder of the day and to avoid strenuous activities. Additionally, they may be instructed to watch for any signs of complications, such as heavy bleeding, severe abdominal pain, or leakage of amniotic fluid. Follow-up appointments may be scheduled to discuss the results of the amniotic fluid analysis and any further steps that may be necessary based on those results.

Short Descr AMNIOCENTESIS DIAGNOSTIC
Medium Descr AMNIOCENTESIS DIAGNOSIC
Long Descr Amniocentesis; diagnostic
Status Code Active Code
Global Days 000 - Endoscopic or Minor Procedure
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 2 - Standard payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 1 - Statutory payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Procedure or Service, Multiple Reduction Applies
ASC Payment Indicator Office-based surgical procedure added to ASC list in CY 2008 or later with MPFS nonfacility PE RVUs; payment based on MPFS nonfacility PE RVUs.
Type of Service (TOS) 2 - Surgery
Berenson-Eggers TOS (BETOS) P6C - Minor procedures - other (Medicare fee schedule)
MUE 2
CCS Clinical Classification 138 - Diagnostic amniocentesis
51 Multiple procedures: when multiple procedures, other than e/m services, physical medicine and rehabilitation services or provision of supplies (eg, vaccines), are performed at the same session by the same individual, the primary procedure or service may be reported as listed. the additional procedure(s) or service(s) may be identified by appending modifier 51 to the additional procedure or service code(s). note: this modifier should not be appended to designated "add-on" codes (see appendix d).
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
GC This service has been performed in part by a resident under the direction of a teaching physician
Date
Action
Notes
2011-01-01 Changed Short description changed.
2002-01-01 Changed Code description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"